Strength Seen in Conatus Pharmaceuticals (CNAT): Stock Soars 56.7% - Tale of the Tape

Loading...
Loading...
Conatus Pharmaceuticals Inc. CNAT was a big mover last session, as the company saw its shares rise nearly 57% on the day. The move came on solid volume with more than 6 million shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.34 to $6.24 in the past one-month time frame.

The company has seen two positive estimate revisions in the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Conatus Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked medical stocks worth considering include Cardica Inc. CRDC, ICU Medical, Inc. ICUI and NeuroMetrix Inc. NURO. All these stocks have a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report


CONATUS PHARMA CNAT: Free Stock Analysis Report

CARDICA INC CRDC: Free Stock Analysis Report

ICU MEDICAL INC ICUI: Free Stock Analysis Report

NEUROMETRIX INC NURO: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Loading...
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...